Maravai Lifesciences Holdings Inc (MRVI) — Cash Flow Reinvestment Rate
Maravai Lifesciences Holdings Inc (MRVI) has a Cash Flow Reinvestment Rate of 0.09x as of June 2026, reinvesting $370.00K (capex $370.00K ) from operating cash flow of $3.99 Million. See Maravai Lifesciences Holdings Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Maravai Lifesciences Holdings Inc Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Maravai Lifesciences Holdings Inc across 6 annual periods. For the full cash flow conversion analysis, see Maravai Lifesciences Holdings Inc cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Maravai Lifesciences Holdings Inc (2019–2024)
Year-by-year capital reinvestment analysis for Maravai Lifesciences Holdings Inc. See Maravai Lifesciences Holdings Inc (MRVI) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 7.23x | $53.97 Million | $7.46 Million | $29.66 Million | ▲ +371.7% |
| 2023 | 1.53x | $193.48 Million | $126.22 Million | $65.55 Million | ▲ +188.6% |
| 2022 | 0.53x | $284.70 Million | $535.98 Million | $17.09 Million | ▲ +62.5% |
| 2021 | 0.33x | $120.50 Million | $368.57 Million | $14.85 Million | ▲ +58.1% |
| 2020 | 0.21x | $31.48 Million | $152.19 Million | $25.41 Million | ▼ -85.5% |
| 2019 | 1.42x | $34.30 Million | $24.11 Million | $17.15 Million | — |